Article
Sandoz launches rival version of AbbVie's arthritis drug Humira
Rating:
0.0
Views:
77
Likes:
1
Library:
1
Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc's big selling arthritis treatment Humira, adding to U.S. competition for the drug that started in January.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value